HealthNewsXtra
All the trending global health news
Thursday, October 22, 2026
Beyond boreholes: Nestlé pushes sustainable water access in Ogun, Abuja
Wednesday, October 21, 2026
Experimental cancer pill that targets DNA of tumour cells debuts
By Admin
Scientists are testing an experimental cancer drug designed to exploit a weakness in cancer cells, raising hopes for a new approach to treating the disease, although its safety and effectiveness in humans remain unproven.
The drug, AOH1996, developed by researchers at City of Hope, a US cancer research and treatment organisation, targets a protein known as proliferating cell nuclear antigen (PCNA), which plays a critical role in DNA replication and repair.
By interfering with this process, the drug aims to disrupt cancer cells’ ability to copy their DNA and multiply, potentially slowing or stopping tumour growth.
In laboratory experiments, AOH1996 demonstrated activity against more than 70 types of cancer cells, while causing less harm to the healthy cells tested, according to research published in Cell Chemical Biology in 2023.
The researchers also evaluated the drug in animal studies before advancing it to early human testing.
As of October 2026, AOH1996 remains an experimental drug under Phase 1 clinical investigation. The US National Cancer Institute lists clinical trials examining its use in patients with advanced solid tumours and certain blood cancers.
These early-stage studies are designed primarily to assess the drug’s safety, side effects and appropriate dosage, while also looking for preliminary evidence that it can benefit patients. They are not intended to establish definitive proof of effectiveness.
The research is significant because cancer cells depend on DNA replication to sustain their rapid growth. Targeting the machinery involved in this process could provide a different way to attack tumours, including cancers that respond poorly to existing treatments.
However, promising laboratory findings do not guarantee that a drug will work safely or effectively in people. AOH1996 must undergo further testing to establish whether its potential benefits outweigh its risks and whether it can improve outcomes for cancer patients.
The findings offer a possible new direction in cancer drug development, but AOH1996 is not an approved or established cancer treatment. Its ultimate value will depend on the results of ongoing clinical trials and subsequent research.
The study, led by scientists at City of Hope, was published in Cell Chemical Biology in 2023 under the title “AOH1996: A small molecule targeting cancer-associated proliferating cell nuclear antigen (PCNA).”
Tuesday, October 20, 2026
Pistis Foundation’s free medical outreach records 58,394 interventions since 2019
By Admin
The Pistis Foundation’s flagship medical and surgical outreach, UBOMI, has recorded 58,394 medical interventions and reached more than 22,811 beneficiaries since 2019, providing free healthcare to people who might otherwise struggle to afford treatment.
The programme was established to address barriers to essential healthcare in underserved communities, bringing together healthcare professionals, technical partners and volunteers to make medical attention and treatment more accessible.
Its September 2026 outreach in Ibadan recorded 10,292 medical interventions and reached 3,611 beneficiaries over five days, from September 21 to 25.
The exercise offered consultations, laboratory screening, pharmacy services, eye and dental care, as well as surgical procedures. The Foundation said the results formed part of UBOMI’s broader effort to expand access to healthcare beyond Lagos and reduce the financial burden that often prevents people from seeking timely medical attention.
Meanwhile, the Lagos edition, which began on October 19, is ongoing and will end on Friday, October 23, 2026. The five day outreach is taking place at Pistis Annex, No. 3 Remi Olowude Street, Marwa Bus Stop, Lekki, Eti-Osa, Lagos.
The Lagos programme provides consultations, diagnostic investigations, eye and dental care, surgery and prescribed medication, subject to clinical assessment and service availability. All services are free to beneficiaries.
According to the Foundation, UBOMI’s impact extends beyond the number of procedures performed, particularly for people whose conditions have gone untreated because of the cost of healthcare. Timely access to diagnosis and treatment can improve health outcomes, independence and quality of life.
The Foundation attributed the programme’s continued delivery to collaboration among healthcare professionals, technical partners, volunteers, donors and other supporters.
Pistis Foundation is the social impact arm of The Elevation Church. Its work spans healthcare, education, child protection and empowerment through initiatives including Adopt-A-Pistis-Scholar, which supports educational opportunities for children, and Kids-Off-The-Street, which focuses on protecting and empowering vulnerable children.
Pastor Godman Akinlabi, Founder and Global Lead Pastor of The Elevation Church, founded Pistis Foundation and serves as chairman of its board.
Through UBOMI, the Foundation continues to work towards reducing financial barriers to essential healthcare and extending access to underserved communities.
Uganda seeks details of Nigeria’s confirmed Ebola case
By Admin
Uganda has asked Nigeria to provide detailed travel and clinical records of a woman confirmed to have the Ebola virus disease in the Federal Capital Territory (FCT) Abuja, following Nigeria’s confirmation of the infection.
Nigeria confirmed the Ebola case on Tuesday, after laboratory testing of the index case, a woman who recently arrived in Nigeria after travelling from Uganda, and currently is receiving medical care in isolation.
In a statement, Prof. Charles Olaro, the Director General of Health Services, Uganda Ministry of Health, said the information was required to guide further investigations and determine whether additional contact tracing was necessary, even as he stressed that the woman’s transit through Uganda did not establish that she contracted the virus there.
The statement, issued in Kampala, said the Ministry of Health was awaiting further information from the Nigerian government to help establish the circumstances surrounding the infection, stating that it would strengthen screening and other public health measures at points of entry in collaboration with relevant agencies.
Preliminary information cited by the Ugandan authorities revealed that the woman, who travelled to the eastern Democratic Republic of the Congo for business, transited through Uganda in early October without showing symptoms, but reportedly developed symptoms after arriving in Nigeria, as the location where she contracted the virus remains under investigation.
The statement titled “Reported Ebola Case in Nigeria: Ministry Calls for Calm and Vigilance” reads in part: “The Ministry of Health has noted reports of a confirmed Ebola case in Nigeria involving a Nigerian woman who reportedly travelled to the eastern Democratic Republic of the Congo for business.
“Preliminary information indicates that she transited through Uganda in early October without showing symptoms and developed symptoms after arriving in Nigeria. Her transit through Uganda does not establish that she contracted the infection there. The location of exposure remains under investigation.
“The Government of Nigeria is yet to provide detailed information on the woman's travel itinerary and clinical history to guide further investigations and any necessary contact tracing.
“The Ministry wishes to clarify that, as of the date of this statement, Uganda has no confirmed active Ebola cases.”
It said limited provisions had been maintained to facilitate humanitarian and diplomatic movements. The Ministry, working with relevant agencies, will further strengthen screening and public health measures at points of entry.
Ebola: Be wary of handshakes, hugs, Academy of Medical Sciences cautions
Ebola case: Nigeria activates emergency response in FCT, tracks 44 contacts
By Admin
The Federal Government has activated emergency public health measures, launched contact tracing for 44 people and intensified disease surveillance after confirming an Ebola case in the Federal Capital Territory (FCT) on Tuesday.
The response, led by the Federal Ministry of Health and Social Welfare and the Nigeria Centre for Disease Control and Prevention (NCDC), includes isolating the case, strengthening infection control, and tracking people who may have been exposed to the virus.
The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, announced the case on Tuesday following laboratory confirmation.
In a statement, Pate said the patient, a woman who recently arrived in Nigeria on an international flight from Uganda, had spent several days receiving treatment at a private hospital in the FCT before the diagnosis was confirmed. She is currently in isolation and receiving medical care.
He said health authorities have commenced contact tracing to identify and monitor people who may have been exposed to the infection, including healthcare workers, patients, caregivers and travel contacts.
The statement reads: “The Federal Government of Nigeria confirmed one case of Ebola disease in the Federal Capital Territory (FCT), following laboratory confirmation today, 20 October 2026.
“The patient, a woman who recently arrived in Nigeria on an international flight from Uganda, was admitted to a private hospital in the FCT, where she received care for several days before the diagnosis was confirmed. She is currently in isolation and receiving medical care.
“The Federal Minister of Health and Social Welfare and NCDC are working closely with the FCT Health Services Secretariat and other relevant authorities to contain the infection and prevent further spread.
“Contact tracing has commenced with 44 close contacts identified presently, with public health teams identifying and monitoring people who may have been exposed, including healthcare workers, patients, caregivers and travel contacts. Surveillance has been intensified, and the hospital is receiving immediate support to strengthen infection prevention and control measures.
“The FG calls on all public and private healthcare facilities nationwide to be on high alert. Healthcare workers must maintain a high index of suspicion, promptly identify and isolate suspected cases, observe strict infection prevention and control measures, and immediately report suspected cases to public health authorities.”
Noting that Ebola spreads through direct contact with the blood or body fluids of someone who is sick with the disease or has died from it, or through contact with contaminated materials, the statement said a person with Ebola cannot spread the disease before symptoms begin.
Pate urged public and private healthcare facilities nationwide to remain on high alert, maintain a high index of suspicion and promptly isolate and report suspected cases. He also called on healthcare workers to observe strict infection prevention and control measures.
Ebola spreads through direct contact with the blood or other body fluids of an infected person who has developed symptoms, or someone who has died from the disease. Transmission can also occur through contact with contaminated materials.
According to the minister, infected people cannot transmit the disease before symptoms begin. However, the public has been advised to watch for symptoms, including fever, severe weakness, headache, vomiting and diarrhoea, particularly after possible exposure.
“We advise everyone to remain calm but vigilant. There is no need for panic. Practise regular hand hygiene and avoid contact with the body fluids of anyone suspected to have Ebola.
“Watch for symptoms, including fever, severe weakness, headache, vomiting and diarrhoea, particularly following possible exposure.
“Report any possible exposure immediately, even if you feel well. If you develop symptoms, avoid close contact with others and call public health authorities for guidance before visiting a healthcare facility.
“Anyone who suspects exposure has been urged to report immediately, even without symptoms. Those who develop symptoms should avoid close contact with others and call public health authorities for guidance before visiting a healthcare facility,” the statement stressed.
The government also urged people identified during contact tracing, including relevant airline passengers, to cooperate with health officials and follow public health advice.
Reassuring Nigerians, Pate said the country had successfully contained an Ebola outbreak in 2014 and had the experience and public health systems needed to respond to the current case. However, he stressed that containing the infection would require public cooperation, early detection and prompt reporting.
He cautioned against spreading rumours or stigmatising affected persons, urging Nigerians to rely on verified information from official health authorities.
The Federal Government said investigations were ongoing and that further updates would be provided through the Presidential Task Force on Ebola Virus Disease and the NCDC.
“We urge Nigerians to remain calm, stay vigilant and cooperate with public health authorities. Early detection, prompt reporting and everyone's cooperation are critical to preventing further spread.”
“The Federal Government, FCT authorities and other partners are working together to protect healthcare workers, patients and the wider public. Investigations are ongoing, and we will continue to provide accurate and timely information.
“The Government of Nigeria through the Presidential Taskforce on EVD and NCDC will continue to provide updates. NCDC free call centre is available 24 hours a day, seven days a week. For information or to report a suspected case, please call NCDC toll-free number 6232.
LASHMA, Zamba bag Presidency GOVTECH Awards 2026
By Admin
The Lagos State Health Management Agency (LASHMA) and its Permanent Secretary, Dr. Emmanuella Zamba, have been honoured with top national accolades at the Nigeria GOVTECH Public Service Awards 2026, organized by the Bureau of Public Service Reforms (BPSR), The Presidency.
During a ceremony held at the Banquet Hall of the Presidential Villa in Abuja, LASHMA was named the Best State MDA in Digital Health Service Delivery (2026), while Dr. Zamba received the GOVTECH Trailblazer’s Award for exemplary leadership, technological adoption, and public sector institutional transformation.
Presenting the honours to Dr. Zamba and LASHMA’s Head of Business Development, Mr. Olatunji Rotimi, the Director-General of BPSR, Mr. Dasuki Arabi, commended the agency for pioneering digital solutions within Nigeria's social health insurance landscape.
Mr. Arabi revealed that LASHMA emerged victorious following a rigorous nationwide nomination process and an independent comparative review. He highlighted the agency's fully digitized infrastructure—ranging from enrollment and payments to regulatory systems—noting that corporate organizations can now seamlessly apply and pay for their Corporate Identification Number online.
He noted that LASHMA’s unified digital database currently supports nearly two million ILERA EKO enrollees, including over 200,000 self-registrations. With more than 800 healthcare providers digitally linked to the agency, LASHMA efficiently processes approximately 80,000 pre-authorizations and claims every month.
The Director-General further praised the agency's expanded digital ecosystem, citing its Telemedicine platform, Virtual Health Booths, integrated Customer Relationship Management system, digital vulnerability assessments, and the ILERA EKO Spotlight Online Radio initiative for driving public awareness and health insurance coverage.
Arabi urged LASHMA to maintain its momentum toward achieving Universal Health Coverage in Lagos State, reminding the leadership that the reward for hard work is more work.
Receiving the awards, Zamba expressed gratitude to the Presidency and BPSR for recognizing LASHMA's commitment to delivering affordable, equitable, and quality healthcare to Lagos residents. She reaffirmed the agency’s resolve to accelerate enrollment under the ILERA EKO scheme, eliminate out-of-pocket medical expenses, and safeguard households from catastrophic health spending.
The Bureau of Public Service Reforms (The Presidency) Award is the fourth Award received by LASHMA in 2026 reinforcing its standing as a national benchmark for digital governance and public health administration.
Beyond boreholes: Nestlé pushes sustainable water access in Ogun, Abuja
By Admin Nestlé Nigeria Plc has commissioned eight climate-smart boreholes and water treatment plants in communities within the ...
-
...Clinches NHEA Award for 3rd time The Permanent Secretary, Lagos State Health Management Agency (LASHMA), Dr. Emmanuella Zamba (4th left)...
-
By Sola Charles Key stakeholders in the Lagos State health sector have consented to a strengthened commitment and partnership on...
-
By Sola Ogundipe Lagos State has recorded a major breakthrough in routine and HPV immunisation awareness, and uptake through the...